Melbourne researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.
Dr Ben Shields and Dr Matt McCormack from the Walter and Eliza Hall Institute’s Cancer and Haematology division discovered that loss of the Hhex protein put the handbrake on leukaemia cell growth and division. The protein is a critical factor enabling AML cells to grow uncontrollably, a hallmark of cancer.
AML is an aggressive blood cancer that appears suddenly, grows quickly and has a poor prognosis. Existing treatments for AML are associated with serious side-effects. About three quarters of patients relapse after only a short period of treatment, with a five-year survival rate of just 24 per cent.
Dr McCormack said discovering how AML overcame normal cellular controls on growth and division was a breakthrough in the search for new therapies.
“There is an urgent need for new therapies to treat AML,” said Dr McCormack. “We showed blocking the Hhex protein could put the brakes on leukaemia growth and completely eliminate AML in preclinical models. This could be targeted by new drugs to treat AML in humans.”
He said Hhex was a particularly attractive therapeutic target because it was overproduced in leukaemia and, while essential for leukaemia cell growth, was not needed by healthy blood cells.
“Most existing treatments for AML are not cancer cell-specific, and unfortunately kill off healthy cells in the process,” Dr McCormack said.
“Hhex is only essential for the leukaemic cells, meaning we could target and treat leukaemia without toxic effects on normal cells, avoiding many of the serious side-effects that come with standard cancer treatments. We also know that most people with AML have increased levels of Hhex, often associated with adverse outcomes, further indicating it is an important target for new AML drugs.”
Dr Shields said AML cells switched off the controls that strictly manage cell growth and division. “Every cell has control genes that are activated when a cell is stressed, such as in the early stages of cancer, and stop the damaged cell from reproducing.” Dr Shields said.
While these control genes are still present in AML cells, they are switched off through a process called epigenetic modification. “Hhex works by recruiting epigenetic factors to growth control genes, effectively silencing them. This allows the leukaemia cells to reproduce and accumulate more damage, contributing to the speed of AML progression,” Dr Shields said.
Dr McCormack said drugs that inhibit epigenetic modification had been previously used to treat AML, but caused significant toxicity because their targets were also required for normal blood cell function.
“Unlike the epigenetic factors targeted previously, Hhex only regulates a small number of genes and is dispensable for normal blood cells. This gives us a rare opportunity to kill AML cells without causing many side effects,” said Dr McCormack. “We now hope to identify the critical regions of the Hhex protein that enable it to function, which will allow us to design much-needed new drugs to treat AML.”
The Latest on: Leukaemia
via Google News
The Latest on: Leukaemia
- Sinisa Mihajlovic, 51, reveals hospital gave him fake identity as 69-year-old homeless man to treat him for leukaemiaon November 12, 2020 at 7:02 am
BOLOGNA coach Sinisa Mihajlovic has revealed the fake identity he was given to fight leukaemia. The former midfielder kept his job with the Serie A team while he overcame the illness last year.
- NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemiaon November 10, 2020 at 8:58 am
Today’s announcement is good news for many people with chronic lymphocytic leukaemia. NICE has today (Tuesday 10 November 2020) recommended a new chemotherapy-free treatment option for people with ...
- Record number of stem cell donors sign up after Ashley Cain’s plea amid baby daughter’s leukaemia battleon November 9, 2020 at 6:33 am
A record number of stem cell donors have signed up after being moved by Ashley Cain’s plea for fans to do amid his baby daughter’s leukaemia battle. The Ex On The Beach star welcomed his first child, ...
- AstraZeneca: EU Approves Calquence To Treat Chronic Lymphocytic Leukaemiaon November 8, 2020 at 11:45 pm
(AZN.L, AZN) announced Monday that the European Commission has approved Calquence (acalabrutinib) to treat adult patients with Chronic Lymphocytic Leukaemia or CLL. Calquence is a next-generation ...
- AstraZeneca: Calquence approved in the EU for the treatment of chronic lymphocytic leukaemiaon November 8, 2020 at 11:24 pm
SvD Näringsliv - nyheter inom ekonomi och näringsliv, aktier och börs. Bevakning av internationella affärer och marknader. Motor- och IT-nyheter.
- Leukaemia patient, 71, infectious with coronavirus for at least 70 dayson November 6, 2020 at 7:31 am
(Stock, Getty Images) A leukaemia patient is thought to have been infectious with the coronavirus for at least 70 days. Since the coronavirus outbreak emerged, experts have questioned how long a ...
- Children in Need: 'A lifeline as our son fights leukaemia in pandemic'on November 6, 2020 at 5:23 am
Seven-year-old Alfie, who has Down's syndrome, was diagnosed with leukaemia nine months ago and his family had to completely isolate themselves to protect him. Help was, however, at hand. This is how ...
- Leukaemia Therapeutics Market 2020 Size Industry Trends, Global Competitors Strategy, Segments, Regional Analysison November 6, 2020 at 2:45 am
Kenneth Research has released a report on Leukaemia Therapeutics Market which is anticipated to grow significantly over ...
- Ashley Cain fights back tears as he reveals 12-week-old daughter will need bone marrow transplant in Leukaemia battleon November 5, 2020 at 1:07 am
ASHLEY Cain fought back tears as he revealed that his 12-week-old daughter Azaylia will need a bone marrow transplant regardless of how well her chemotherapy goes. The 30-year-old star told fans ...
via Bing News